A new study of veterans' medical histories published in the journal Science finds that the effectiveness of all three COVID-19 vaccines available in America dramatically dropped as the months wore on by double-digit levels, in fact. That's science, folks.
Pfizer CEO Albert Bourla said Friday he will ask the Food and Drug Administration to authorize by Thanksgiving a groundbreaking pill for treating COVID-19 after the drugmaker announced "game-changer" results from its clinical trial.
Maryland officials said Wednesday they expect about a third of children ages 5 to 11 to get vaccinated against COVID-19 in the next three to four weeks, following federal approval Tuesday night of Pfizer-BioNTech's shots.